LOS ANGELES, April 23, 2008 (PRIME NEWSWIRE) -- Universal Detection Technology (OTCBB:UDTT) (Frankfurt:PO8) (www.udetection.com), a developer of early warning monitoring technologies to protect people from bioterrorism and a provider of counter terrorism training and solutions, announced today that it has received a purchase order from an Israeli company for the Company's Hand Held Assays (HHA).
The Israeli government as well as private security firms are actively improving their preparedness for a bioterror attack as the potential threat of such an attack from terror organizations and states with active biological weapon programs, such as Syria, grows. As an example, large numbers of the Israeli population have received smallpox inoculations.
UDTT's anthrax detection HHAs have provided accurate results to users in the field in as little as three minutes. The assays have been purchased by first responders throughout the country as well as the U.S. Army. The kits are able to detect anthrax spores well below the threshold for an infectious dose.
"We have seen increased interest in our bioterrorism detection kits recently from Israeli security firms and we hope that this trend can open up doors to more international sales of UDTT's HHAs," said Mr. Jacques Tizabi, UDTT's Chief Executive Officer.
For more information please visit our website at www.udetection.com or
Email us at info@udetection.com.
About Universal Detection Technology
Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA, has developed a bioterror 'smoke' detector that detects certain bio hazard substances. For more information, please visit http://www.udetection.com.
The Universal Detection Technology logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=4911
Forward-Looking Statements
Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.